Le Lézard
Classified in: Science and technology, Covid-19 virus
Subjects: Contract/Agreement, Product/Service

MDClone Forms Unique Research and Innovation Network With Global Health Leaders


MDClone, a digital health company, together with leading healthcare organizations from around the world, announced today the founding of The Global Network - a research and knowledge sharing collaborative. The Global Network leverages the MDClone platform to democratize data by organizing complex patient information and protecting patient privacy with synthetic data. Addressing an important barrier in cross-institution collaboration, synthetic data will allow for robust analysis using data which contains no individual patient information. The MDClone platform offers a framework to better understand the health of patients and develop solutions for care delivery. Using the platform installed across The Global Network sites, members will develop solutions and explore ideas together to improve patient health.

"MDClone provides access to data as never before," said Ziv Ofek, Founder and CEO. "In a short time, we've seen dramatic impacts with physicians implementing new quality initiatives and researchers moving from idea to publication. The Global Network will take this to another level by connecting some of the world's most innovative healthcare organizations and transforming insights into action. Ultimately, The Global Network will create new technologies and services, built-in collaboration across the membership and benefits for patients worldwide."

In its first year, The Global Network will focus on three pillars of research: health services, clinical medicine and precision medicine. Members will be able to conduct projects within multiple sites, including study design and replication, testing new approaches and partnering with external healthcare organizations. These projects can be conducted without sharing individual patient information, utilizing synthetic data generated by MDClone at each member site from over 30 million total patients within the network.

Hear from the leading voices in healthcare as they discuss the goals and unique opportunity of The Global Network. Watch Now: The Global Network powered by MDClone

The virtual launch includes:

MDClone's platform, already installed in numerous health systems, has yielded impressive results. The platform turns cycles of discovery from months and years to hours and days through self-service exploration and access to synthetic data without IRB approval. Examples of MDClone in action include building a program for managing the chronic kidney disease population at Intermountain Healthcare, a machine-learning model for predicting sepsis at Washington University School of Medicine in St. Louis, evaluating side effects of immunotherapy on oncology patients at Sheba Medical Center and optimizing insulin treatment for diabetic patients at Rambam Health Care Campus in Israel. Some of the first projects underway in The Global Network are focused on understanding treatments and outcomes for patients with COVID-19. The members will establish additional opportunities for working within The Global Network at its first meeting in Summer 2020.

About MDClone
MDClone democratizes data, empowering exploration, discovery and collaboration to improve patients' health. With MDClone, any user can ask and answer any question in real time. This dramatic paradigm shift is made possible by MDClone's unique technology for organizing, accessing and protecting the privacy of patient data, enabling healthcare knowledge workers to transform ideas into actionable insights in rapid cycles. Founded in 2016 in Israel, MDClone works with major health systems, payers and life science companies in the U.S., Canada and Israel.

About The Global Network powered by MDClone
The Global Network powered by MDClone is a collaborative environment where ideas can be leveraged from across the healthcare ecosystem to improve patient health. Member-driven, The Global Network includes healthcare organizations from the U.S., Canada and Israel:


These press releases may also interest you

at 13:15
The "Long-Acting Drug Delivery Technologies and Services Market: A Global and Regional Analysis, 2023-2033" report has been added to ResearchAndMarkets.com's offering. As of 2022, the global long-acting drug delivery technologies and services...

at 13:07
While many schools will be closed on April 8, 2024 for the total solar eclipse, Western Reserve Academy (WRA) in Hudson, OH is using the day to celebrate its place in the path of totality, and its place in history....

at 13:05
Regulatory News: MaaT Pharma (EURONEXT: MAAT ? the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival of patients with cancer, today reported...

at 13:03
Gale, part of Cengage Group, is continuing its support of academic initiatives in diversity, equity and inclusion (DEI) with the release of four new archives on the Gale Primary Sources (GPS) platform. These archives unlock perspectives on...

at 13:00
Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Lantronix, Inc. ("Lantronix" or the "Company") ....

at 13:00
The "Space-Based Laser Communication Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering. World revenue for the Space-Based Laser Communication Market is forecast to surpass US$ 1.76 billion in 2024, with strong...



News published on and distributed by: